Abstract:Abstract Background Genome-wide association studies have identified genetic variants associated with the risk of brain-related diseases, such as neurological and psychiatric disorders, while the causal variants and the specific vulnerable cell types are often needed to be studied. Many disease-associated genes are expressed in multiple cell types of human brains, while the pathologic variants affect primarily specific cell types. We hypothesize a model in which what determines the manifestation of a disease in a cell type is the presence of disease module comprised of disease-associated genes, instead of individual genes. Therefore, it is essential to identify the presence/absence of disease gene modules in cells. Methods To characterize the cell type-specificity of brain-related diseases, we construct human brain cell type-specific gene interaction networks integrating human brain nucleus gene expression data with a referenced tissue-specific gene interaction network. Then from the cell type-specific gene interaction networks, we identify significant cell type-specific disease gene modules by performing statistical tests. Results Between neurons and glia cells, the constructed cell type-specific gene networks and their gene functions are distinct. Then we identify cell type-specific disease gene modules associated with autism spectrum disorder and find that different gene modules are formed and distinct gene functions may be dysregulated in different cells. We also study the similarity and dissimilarity in cell type-specific disease gene modules among autism spectrum disorder, schizophrenia and bipolar disorder. The functions of neurons-specific disease gene modules are associated with synapse for all three diseases, while those in glia cells are different. To facilitate the use of our method, we develop an R package, CtsDGM, for the identification of cell type-specific disease gene modules. Conclusions The results support our hypothesis that a disease manifests itself in a cell type through forming a statistically significant disease gene module. The identification of cell type-specific disease gene modules can promote the development of more targeted biomarkers and treatments for the disease. Our method can be applied for depicting the cell type heterogeneity of a given disease, and also for studying the similarity and dissimilarity between different disorders, providing new insights into the molecular mechanisms underlying the pathogenesis and progression of diseases.

Protocol for Analyzing Functional Gene Module Perturbation During the Progression of Diseases Using a Single-Cell Bayesian Biclustering Framework

Single-cell biclustering for cell-specific transcriptomic perturbation detection in AD progression

Bayesian Generalized Biclustering Analysis Via Adaptive Structured Shrinkage.

A Parametric Model for Clustering Single-Cell Mutation Data

A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data

An analytical method for the identification of cell type-specific disease gene modules

Integrative pathway analysis with gene expression, miRNA, methylation and copy number variation for breast cancer subtypes

Incorporating biological information into linear models: A Bayesian approach to the selection of pathways and genes

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Bayesian biclustering for microbial metagenomic sequencing data via multinomial matrix factorization

Functional Integrative Bayesian Analysis of High-dimensional Multiplatform Genomic Data

Outcome-guided Bayesian clustering for disease subtype discovery using high-dimensional transcriptomic data

Use of Bayesian networks to dissect the complexity of genetic disease: application to the Genetic Analysis Workshop 17 simulated data

Peeling Off the Hidden Genetic Heterogeneities of Cancers Based on Disease-Relevant Functional Modules

A Regularized Bayesian Dirichlet-multinomial Regression Model for Integrating Single-cell-level Omics and Patient-level Clinical Study Data

Binary matrix factorization for analyzing gene expression data

Network-aided Bi-Clustering for Discovering Cancer Subtypes

Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics

Excavating the Pathogenic Gene of Breast Cancer Based on High Throughput Data of Tumor and Somatic Reprogramming

Identifying Disease Feature Genes Based on Cellular Localized Gene Functional Modules and Regulation Networks

Scgena: A Single-Cell Gene Coexpression Network Analysis Framework for Clustering Cell Types and Revealing Biological Mechanisms